Public review for Cross-Enterprise Security and Privacy Authorization (#XSPA) Profile of SAML v2.0 for Healthcare Version 2.0 - ends December 18th

The OASIS Cross-Enterprise Security and Privacy Authorization (XSPA) TC members [1] have produced an updated Committee Specification Draft (CSD) and submitted this specification for 15-day public review:

Cross-Enterprise Security and Privacy Authorization (XSPA) Profile of SAML v2.0 for Healthcare Version 2.0
Committee Specification Draft 03 / Public Review Draft 03
26 November 2018

What is the XSPA Profile of SAML and why is it important?

The XSPA profile defines a set of SAML attributes and corresponding vocabularies for healthcare information exchange applications.

The core use-cases are the cross-enterprise exchange of protected data objects from a Service Provider (SP) to a Service Consumer (SC). In the scenarios, the request includes SAML attribute assertions that vouch for the identity of the requesting Principal and other attributes that are consequential in making the access control decision at the SP’s side.

In addition to the main use-cases, the attributes name and values can be used in some other scenarios, such as including SAML Assertions to vouch for some of SP’s organizational attributes, or carrying the identity attributes of the signer of a data object.

Public Review Period:

The public review starts 04 December 2018 at 00:00 UTC and ends 18 December 2018 at 11:59 UTC. The specification was previously submitted for public review [2].

This is an open invitation to comment. OASIS solicits feedback from potential users, developers and others, whether OASIS members or not, for the sake of improving the interoperability and quality of its technical work.

URIs:
The prose specification document and related files are available here:
Editable source (Authoritative):
https://docs.oasis-open.org/xspa/saml-xspa/v2.0/csprd03/saml-xspa-v2.0-c...
HTML:
https://docs.oasis-open.org/xspa/saml-xspa/v2.0/csprd03/saml-xspa-v2.0-c...
PDF:
https://docs.oasis-open.org/xspa/saml-xspa/v2.0/csprd03/saml-xspa-v2.0-c...

ZIP distribution files (complete):
For your convenience, OASIS provides a complete package of the prose specification and related files in a ZIP distribution file. You can download the ZIP file here:
https://docs.oasis-open.org/xspa/saml-xspa/v2.0/csprd03/saml-xspa-v2.0-c...

Additional information about this specification and the XSPA TC may be found on the TC's public home page located at:
https://www.oasis-open.org/committees/xspa/

Comments may be submitted to the TC by any person through the use of the OASIS TC Comment Facility which can be accessed via the button labeled "Send A Comment" at the top of the TC public home page, or directly at:
https://www.oasis-open.org/committees/comments/form.php?wg_abbrev=xspa

Feedback submitted by TC non-members for this work and for other work of this TC is publicly archived and can be viewed at:
https://lists.oasis-open.org/archives/xspa-comment/

All comments submitted to OASIS are subject to the OASIS Feedback License, which ensures that the feedback you provide carries the same obligations at least as the obligations of the TC members. In connection with this public review of 'Cross-Enterprise Security and Privacy Authorization (XSPA) Profile of SAML v2.0 for Healthcare Version 2.0', we call your attention to the OASIS IPR Policy [3] applicable especially [4] to the work of this technical committee. All members of the TC should be familiar with this document, which may create obligations regarding the disclosure and availability of a member's patent, copyright, trademark and license rights that read on an approved OASIS specification.

OASIS invites any persons who know of any such claims to disclose these if they may be essential to the implementation of the above specification, so that notice of them may be posted to the notice page for this TC's work.

========== Additional references:

[1] OASIS Cross-Enterprise Security and Privacy Authorization (XSPA) TC
https://www.oasis-open.org/committees/xspa/

[2] Previous public reviews:
- 30-day public review, 29 April 2014:
https://lists.oasis-open.org/archives/members/201404/msg00010.html
- Comment resolution log:
https://docs.oasis-open.org/xspa/saml-xspa/v2.0/csprd01/saml-xspa-v2.0-c...
- 15-day public review, 27 March 2017:
https://lists.oasis-open.org/archives/xspa/201703/msg00006.html
- Comment resolution log:
https://docs.oasis-open.org/xspa/saml-xspa/v2.0/csprd02/saml-xspa-v2.0-c...

[3] https://www.oasis-open.org/policies-guidelines/ipr

[4] https://www.oasis-open.org/committees/xspa/ipr.php
https://www.oasis-open.org/policies-guidelines/ipr#RF-on-Limited-Mode
RF on Limited Terms Mode

Associated TC: 
Cross-Enterprise Security and Privacy Authorization (XSPA)